This Article Full Text Full Text (PDF) Supplemental Data Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Afink, G. Articles by Ris-Stalpers, C. Search for Related Content PubMed PubMed Citation Articles by Afink, G. Articles by Ris-Stalpers, C. Related Collections Thyroid

Molecular Characterization of Iodotyrosine Dehalogenase Deficiency in Patients with Hypothyroidism

Laboratories of Pediatric Endocrinology (G.A., J.d.R., T.V., C.R.-S.) and Genetic Metabolic Diseases (W.K., H.O., A.v.C.), Academic Medical Center, University of Amsterdam, 1100 DD Amsterdam, The Netherlands; and Department of Pediatric Endocrinology (M.C.), Ghent University Hospital, B-9000 Ghent, Belgium

Address all correspondence and requests for reprints to: Dr. G. Afink, Laboratory Pediatric Endocrinology, Room G2-133, Academic Medical Center, University of Amsterdam, P.O. Box 22660, 1100 DD Amsterdam, The Netherlands. E-mail: g.b.afink{at}amc.uva.nl.

Context: The recent cloning of the human iodotyrosine deiodinase (IYD) gene enables the investigation of iodotyrosine dehalogenase deficiency, a form a primary hypothyroidism resulting from iodine wasting, at the molecular level.

Objective: In the current study, we identify the genetic basis of dehalogenase deficiency in a consanguineous family.

Results: Using HPLC tandem mass spectrometry, we developed a rapid, selective, and sensitive assay to detect 3-monoiodo-L-tyrosine and 3,5-diodo-L-tyrosine in urine and cell culture medium. Two subjects from a presumed dehalogenase-deficient family showed elevated urinary 3-monoiodo-L-tyrosine and 3,5-diodo-L-tyrosine levels compared with 57 normal subjects without thyroid disease. Subsequent analysis of IYD revealed a homozygous missense mutation in exon 4 (c.658G>A p.Ala220Thr) that co-segregates with the clinical phenotype in the family. Functional characterization of the mutant iodotyrosine dehalogenase protein showed that the mutation completely abolishes dehalogenase enzymatic activity. One of the heterozygous carriers for the inactivating mutation recently presented with overt hypothyroidism indicating dominant inheritance with incomplete penetration. Screening of 100 control alleles identified one allele positive for this mutation, suggesting that the c.658G>A nucleotide substitution might be a functional single nucleotide polymorphism.

Conclusions: This study describes a functional mutation within IYD, demonstrating the molecular basis of the iodine wasting form of congenital hypothyroidism. This familial genetic defect shows a dominant pattern of inheritance with incomplete penetration.